hypericin has been researched along with Cancer of Pancreas in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin was considerably associated with the plasma membrane, appreciably localized in the sub-plasma membrane region and substantially accumulated in the cytoplasm." | 5.42 | Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio. ( Bao, Y; Huang, Y; Li, Y; Sun, L; Wu, Y; Yang, G; Yang, SN; Yang, X; Yi, J; Yu, C; Zheng, L, 2015) |
| "Hypericin was considerably associated with the plasma membrane, appreciably localized in the sub-plasma membrane region and substantially accumulated in the cytoplasm." | 1.42 | Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio. ( Bao, Y; Huang, Y; Li, Y; Sun, L; Wu, Y; Yang, G; Yang, SN; Yang, X; Yi, J; Yu, C; Zheng, L, 2015) |
| "The treatment of pancreatic cancer has remained dismal despite advances in medical and surgical care." | 1.31 | Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. ( Kwan, D; Liu, CD; McFadden, DW; Saxton, RE, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, L | 2 |
| Shang, H | 1 |
| Wu, Y | 2 |
| Xin, X | 1 |
| Yi, J | 1 |
| Yang, X | 1 |
| Zheng, L | 1 |
| Yang, G | 1 |
| Bao, Y | 1 |
| Huang, Y | 1 |
| Yu, C | 1 |
| Yang, SN | 1 |
| Li, Y | 1 |
| Liu, CD | 1 |
| Kwan, D | 1 |
| Saxton, RE | 1 |
| McFadden, DW | 1 |
3 other studies available for hypericin and Cancer of Pancreas
| Article | Year |
|---|---|
Hypericin-mediated photodynamic therapy enhances gemcitabine induced Capan-2 cell apoptosis via inhibiting NADPH level.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; NA | 2022 |
Hypericin-mediated photodynamic therapy enhances gemcitabine induced Capan-2 cell apoptosis via inhibiting NADPH level.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; NA | 2022 |
Hypericin-mediated photodynamic therapy enhances gemcitabine induced Capan-2 cell apoptosis via inhibiting NADPH level.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; NA | 2022 |
Hypericin-mediated photodynamic therapy enhances gemcitabine induced Capan-2 cell apoptosis via inhibiting NADPH level.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; NA | 2022 |
Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.
Topics: Animals; Anthracenes; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survi | 2015 |
Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo.
Topics: Animals; Anthracenes; Antineoplastic Agents; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Perylen | 2000 |